{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:21:01Z","timestamp":1648988461840},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T00:00:00Z","timestamp":1242432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00105-009-1770-9","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T13:45:27Z","timestamp":1242308727000},"page":"505-515","source":"Crossref","is-referenced-by-count":5,"title":["Vitiligo"],"prefix":"10.1007","volume":"60","author":[{"given":"A.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,16]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2230.2005.02004.x","volume":"31","author":"Aydogan","year":"2006","unstructured":"Aydogan K, Turan OF, Onart S et al (2006) Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol 31:110\u2013113","journal-title":"Clin Exp Dermatol"},{"key":"1770_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000249466","volume":"171","author":"Betterle","year":"1985","unstructured":"Betterle C, Caretto A, De Zio A et al (1985) Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatol 171:419\u2013423","journal-title":"Dermatol"},{"key":"1770_CR3","first-page":"852","volume":"21","author":"Falabella","year":"1995","unstructured":"Falabella R, Barona M, Escobar C et al (1995) Surgical combination therapy for vitiligo and piebaldism. Dermatol Surg 21:852\u2013857","journal-title":"Dermatol Surg"},{"key":"1770_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","volume":"22","author":"Falabella","year":"2009","unstructured":"Falabella R, Barona M (2009) Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma Res 22:42\u201366","journal-title":"Pigment Cell Melanoma Res"},{"key":"1770_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"Gawkrodger","year":"2008","unstructured":"Gawkrodger DJ, Ormerod AD, Shaw L et al (2008) Guideline for the diagnosis and management of vitiligo. Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists; Clinical Standards Department, Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Br J Dermatol 159:1051\u20131076","journal-title":"Br J Dermatol"},{"key":"1770_CR6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","volume":"35","author":"Hann","year":"1996","unstructured":"Hann SK, Lee HJ (1996) Segmental vitiligo: Clinical findings in 208 patients. J Am Acad Dermatol 35:671\u2013674","journal-title":"J Am Acad Dermatol"},{"key":"1770_CR7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02154.x","volume":"44","author":"Hartmann","year":"2005","unstructured":"Hartmann A, Lurz CH, Hamm H et al (2005) Narrow-band versus broad-band UVB phototherapy in combination with calcipotriol versus placebo in vitiligo. Int J Dermatol 44:736\u2013742","journal-title":"Int J Dermatol"},{"key":"1770_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1610-0387.2007.06236.x","volume":"5","author":"Hartmann","year":"2007","unstructured":"Hartmann A, L\u00f6hberg L, Zajitschek J, Schuler G (2007) Intense-Pulsed-Light (IPL)UVB-phototherapy: first efficacy and safety results in repigmentation of generalized vitiligo. J Dtsch Dermatol Ges 5:164","journal-title":"J Dtsch Dermatol Ges"},{"key":"1770_CR9","unstructured":"Hartmann A (2008) Pigmentst\u00f6rungen. Derma-Net-Online (http:\/\/www.derma-netonline.de); Kap 13:1\u201326"},{"key":"1770_CR10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1610-0387.2008.06755.x","volume":"6","author":"Hartmann","year":"2008","unstructured":"Hartmann A, Bedenk C, Keikavoussi P et al (2008) Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features. J Dtsch Dermatol Ges 6:1053\u20131059","journal-title":"J Dtsch Dermatol Ges"},{"key":"1770_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-0464","volume":"88","author":"Hartmann","year":"2008","unstructured":"Hartmann A, Br\u00f6cker EB, Hamm H (2008) Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. Acta Derm Venereol 88:474\u2013479","journal-title":"Acta Derm Venereol"},{"key":"1770_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1610-0387.2007.06455.x","volume":"6","author":"Hartmann","year":"2008","unstructured":"Hartmann A, Br\u00f6cker EB, Hamm H (2008) Repigmentation of vitiligo of the lower legs by topical 0.1% tracolimus ointment compared to 1% pimecrolimus cream under occlusion. J Dtsch Dermatol Ges 6:383\u2013385","journal-title":"J Dtsch Dermatol Ges"},{"key":"1770_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1468-3083.2007.02407.x","volume":"22","author":"Hartmann","year":"2008","unstructured":"Hartmann A, Br\u00f6cker EB, Hamm H (2008) Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension. J Eur Acad Dermatol Venereol 22:624\u2013626","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1770_CR14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/DAD.0b013e3181651511","volume":"30","author":"Kim","year":"2008","unstructured":"Kim YC, Kim YJ, Kang HY et al (2008) Histopathologic features in vitiligo. Am J Dermatopathol 30:112\u2013116","journal-title":"Am J Dermatopathol"},{"key":"1770_CR15","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","volume":"177","author":"Lambe","year":"2006","unstructured":"Lambe T, Leung JC, Bouriez-Jones T et al (2006) CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol 177:3055\u20133062","journal-title":"J Immunol"},{"key":"1770_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1468-3083.2003.00743.x","volume":"17","author":"Menchini","year":"2003","unstructured":"Menchini G, Tsoureli-Nikita E, Hercogova J (2003) Narrow-band UV-B microphototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 17:171\u2013177","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1770_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","volume":"9","author":"Nordlund","year":"1983","unstructured":"Nordlund JJ, Kirkwood JM, Forget BM et al (1983) Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689\u2013696","journal-title":"J Am Acad Dermatol"},{"key":"1770_CR18","doi-asserted-by":"crossref","unstructured":"Nordlund JJ, Ortonne JP, Le Poole C (2006) Genetic hypomelanoses: aquired depigmentation. In: Nordlund JJ, Boissy RE et al (eds) The pigmentary system: physiology and pathophysiology, 2nd edn. Blackwell Publ., pp 551\u2013598","DOI":"10.1002\/9780470987100"},{"key":"1770_CR19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90\u2013100","journal-title":"Pigment Cell Res"},{"key":"1770_CR20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2230.2002.01142.x","volume":"27","author":"Patel","year":"2002","unstructured":"Patel DC, Evans AV, Hawk JL (2002) Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 27:641\u2013644","journal-title":"Clin Exp Dermatol"},{"key":"1770_CR21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-4632.2008.03660.x","volume":"47","author":"Schallreuter","year":"2008","unstructured":"Schallreuter KU, Kr\u00fcger C, W\u00fcrfel BA et al (2008) From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol 47:743\u2013753","journal-title":"Int J Dermatol"},{"key":"1770_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0749.2007.00384.x","volume":"20","author":"Spritz-RA","year":"2007","unstructured":"Spritz-RA (2007) The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res 20:271\u2013278","journal-title":"Pigment Cell Res"},{"key":"1770_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","volume":"20","author":"Ta\u00efeb","year":"2007","unstructured":"Ta\u00efeb A, Picardo M, VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27\u201335","journal-title":"Pigment Cell Res"},{"key":"1770_CR24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","volume":"82","author":"Tjioe","year":"2002","unstructured":"Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC (2002) Treatment of vitiligo vulgaris with narrow band UVB (311\u00a0nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82:369\u2013372","journal-title":"Acta Derm Venereol"},{"key":"1770_CR25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","volume":"143","author":"Yones","year":"2007","unstructured":"Yones SS, Palmer RA, Garibaldinos TM, Hawk JL (2007) Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 143:578\u2013584","journal-title":"Arch Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1770-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-009-1770-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1770-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:43Z","timestamp":1558568263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-009-1770-9"}},"subtitle":["Diagnose, Differenzialdiagnose und aktuelle Therapieempfehlungen"],"short-title":[],"issued":{"date-parts":[[2009,5,16]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1007\/s00105-009-1770-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,16]]}}}